Ulcerative Colitis Market Is Probably Going To Grow Remarkably| Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceuticals

The latest survey on Ulcerative Colitis Market is conducted to provide hidden gems performance analysis of Ulcerative Colitis to better demonstrate competitive environment. The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end-use applications. The report bridges the historical data from 2019 to 2023 and forecasted till 2030. The outbreak of the latest scenario in «keyword» market has made companies uncertain about their future outlook as the disturbance in the value chain has made a serious economic slump. Some are the key & emerging players that are part of the coverage and profiled in the study are AbbVie (United States), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (United States), Janssen Pharmaceuticals, Inc. (United States), Ferring Pharmaceuticals (Switzerland), Novartis International AG (Switzerland), Eli Lilly and Company (United States), Bristol Myers Squibb (United States), Celgene Corporation (United States), Boehringer Ingelheim International GmbH (Germany), GlaxoSmithKline plc (United Kingdom), Teva Pharmaceutical Industries Ltd. (Israel), Mitsubishi Tanabe Pharma Corporation (Japan), UCB S.A. (Belgium), AbbVie (United States) are some of the key players that are part of study coverage.

According to HTF Market Intelligence, the Global Ulcerative Colitis Market size is estimated to be around USD Million in 2023 and is expected to grow at a CAGR of 4.09% to reach USD Million by 2030.

Get Access to Statistical Data, Charts & Key Players Strategies
@ https://www.htfmarketintelligence.com/sample-report/global-ulcerative-colitis-market?utm_source=Sweety_OpenPR&utm_id=Sweety

Ulcerative Colitis Market Overview
Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine, also called the colon
Market Drivers
Advancement of personalized medicine stands as a major driver in the ulcerative colitis industry. Also, the shift towards precision medicine holds the promise of improved efficacy and reduced side effects compared to traditional treatments. Additionally, the rise of biologics and biosimilars has transformed the treatment landscape, offering patients alternative options with varying mechanisms of action. Furthermore, the growing adoption of telemedicine and digital health solutions presents an opportunity to enhance patient care through remote monitoring and personalized treatment plans.
Market Opportunities:
The development of novel therapeutic approaches that target the underlying mechanisms of inflammation create opportunities for the market growth. The exploration of novel drug delivery systems, such as targeted nanoparticles and oral biologics, holds promise for enhancing drug efficacy and patient adherence. Additionally, the increasing focus on patient-centric care has created opportunities for holistic treatment approaches that address not only disease symptoms but also the psychosocial impact of UC on patients' quality of life. On October 13, 2023, Pfizer announced that the U.S. FDA approved VELSIPITY (etrasimod) for adults with moderately to severely active ulcerative colitis (UC). VELSIPITY, an oral, once-daily selective sphingosine-1-phosphate (S1P) receptor modulator, offers patients a new treatment option. The approval is based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials, which demonstrated significant clinical remission rates in patients. VELSIPITY achieved 27.0% clinical remission at 12 weeks and 32.0% at 52 weeks in the ELEVATE UC 52 trial, compared to 7.0% for placebo. The ELEVATE UC 12 trial showed 26.0% remission at 12 weeks versus 15.0% for placebo. This milestone provides a convenient, non-injectable therapy for UC patients who have not responded well to conventional or biologic treatments (Harvard Gazette) (Sanofi).
Ulcerative Colitis Market Segmentation

Market Analysis by Types: Medication, Surgery

Know more About Customization @: https://www.htfmarketintelligence.com/enquiry-before-buy/global-ulcerative-colitis-market?utm_source=Sweety_OpenPR&utm_id=Sweety

Important Features that are under offering & key highlights of the Ulcerative Colitis market report:
1. Why lots of Key players are not profiled in the Study?
--> The market study is surveyed by collecting data from various companies from Ulcerative Colitis industry, and the base for coverage is NAICS standards. However, the study is not limited to profiling only a few companies; connect with sales executives to get a customized list. The standard version of the research report is listed with players like AbbVie (United States), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (United States), Janssen Pharmaceuticals, Inc. (United States), Ferring Pharmaceuticals (Switzerland), Novartis International AG (Switzerland), Eli Lilly and Company (United States), Bristol Myers Squibb (United States), Celgene Corporation (United States), Boehringer Ingelheim International GmbH (Germany), GlaxoSmithKline plc (United Kingdom), Teva Pharmaceutical Industries Ltd. (Israel), Mitsubishi Tanabe Pharma Corporation (Japan), UCB S.A. (Belgium), AbbVie (United States) are some of the key players that are part of study coverage.

2. Does the Scope of the Market Study allow further Segmentation?
---> Yes, for a deep dive analysis add-on segmentation is applicable in a premium customized version of the report to better derive market values. The standard version of this report covers segmentation by Application [ ], by Type [Medication, Surgery], and by regions [In North America, In Latin America, Europe, The Asia-pacific, Middle East and Africa (MEA), What are the main countries covered , The United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, Korea, Southeast Asia, India, Australia, Brazil, Mexico, Argentina, Chile, Colombia, Egypt, Saudi Arabia, United Arab Emirates, Nigeria & South Africa]

3. What level of granularity would the Country landscape cover?
---> In the premium version of the report, two-level of regional segmentations allow user to have access to a country-level break-up of market Size by revenue and volume*
* Wherever applicable

4. Does the Study also provide insights into macroeconomic factors?
---> Yes, the study also includes market factor analysis that includes macroeconomic factors, the inflationary cycle and its impact, and Russia-Ukraine war analysis and its effect on the value/supply chain.

For More Information Read Table of Content @ https://www.htfmarketintelligence.com/report/global-ulcerative-colitis-market

HTF MI provides customized studies specific to regional and country-level reports for the following areas.
• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, and Brazil.
• Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt, and South Africa.
• Europe: the United Kingdom, France, Italy, Germany, Spain, and Russia.
• Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, Australia, etc.

Reasons to Buy
• Stay tuned with the latest and Ulcerative Colitis market research findings
• Benchmark performance against key competitors
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Identify segments with hidden growth potential for investment in Ulcerative Colitis
• Gain a global perspective on the development of the Ulcerative Colitis market

Buy Single User PDF and explore latest findings of Ulcerative Colitis Market Study @ https://www.htfmarketintelligence.com/buy-now?format=1&report=8429?utm_source=Sweety_OpenPR&utm_id=Sweety

Thanks for reading Ulcerative Colitis research article; you can also get individual chapter-wise sections or region-wise report versions like LATAM, North America, MENA, Southeast Asia, Europe, APAC or Country Specific reports such as Japan, United Kingdom, United States or China, etc

Nidhi Bhawsar (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Phone: +15075562445
sales@htfmarketreport.com

About Author:
HTF Market Intelligence Consulting is uniquely positioned to empower and inspire with research and consulting services to enable businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events, and experience that assist in decision-making.

This release was published on openPR.